KRT39 as A Drug Target for Glomerulonephritis and Other Diseases

Target Name: KRT39

NCBI ID: G390792

KRT39

KRT39 as A Drug Target for Glomerulonephritis and Other Diseases

KRT39 (Kidney Renal Transplantation Model 39) is a widely used model for the study of glomerulonephritis, a common complication in kidney transplantation. It is a strain of the mouse that has been genetically modified to have a similar function to the human kidney, allowing researchers to study the interactions between the kidney and the surrounding tissues.

KRT39 has been shown to be an effective model for studying glomerulonephritis, with researchers using it to identify potential new treatments for the disease. One of the main advantages of KRT39 is its ability to transmit the effects of drugs to the kidneys, making it a useful tool for testing new treatments for glomerulonephritis.

In addition to its use in research, KRT39 has also been used as a drug target. The molecules found in KRT39 have been shown to be potential drug targets for a variety of diseases, including diabetes, heart disease, and cancer. Researchers are currently exploring the potential of these molecules as new treatments for a variety of diseases.

One of the most promising potential drug targets identified in KRT39 is the protein PDGF-BB. PDGF-BB is a growth factor that has been shown to play a role in the development and progression of a variety of diseases, including cancer. Researchers have found that KRT39 mice with PDGF-BB deleted had reduced glomerulonephritis compared to control mice, suggesting that PDGF-BB may be a potential drug target for the disease.

Another potential drug target found in KRT39 is the protein PDGF-BB-ASF. PDGF-BB-ASF is a variant of the PDGF-BB protein that has been shown to promote the growth and survival of cancer cells. Researchers have found that KRT39 mice with PDGF-BB-ASF had increased cancer cell growth compared to control mice, suggesting that this protein may be a potential drug target for the disease.

In addition to PDGF-BB, KRT39 has also been shown to be sensitive to the drug rapamycin. Rapamycin is an immunosuppressant drug that is used to prevent the rejection of transplanted organs. Researchers have found that KRT39 mice treated with rapamycin had reduced glomerulonephritis compared to control mice, suggesting that rapamycin may be a potential drug for the disease.

Overall, KRT39 has been an important tool for the study of glomerulonephritis and has the potential to be a drug target for a variety of diseases. As research continues to advance, the molecules found in KRT39 will be further explored as potential drug targets and new treatments for a variety of diseases.

Protein Name: Keratin 39

Functions: May play a role in late hair differentiation

The "KRT39 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about KRT39 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets